Nicholas J. Maragakis

11.5k total citations · 3 hit papers
106 papers, 7.4k citations indexed

About

Nicholas J. Maragakis is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Nicholas J. Maragakis has authored 106 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Neurology, 55 papers in Genetics and 29 papers in Molecular Biology. Recurrent topics in Nicholas J. Maragakis's work include Amyotrophic Lateral Sclerosis Research (74 papers), Neurogenetic and Muscular Disorders Research (55 papers) and Neurogenesis and neuroplasticity mechanisms (17 papers). Nicholas J. Maragakis is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (74 papers), Neurogenetic and Muscular Disorders Research (55 papers) and Neurogenesis and neuroplasticity mechanisms (17 papers). Nicholas J. Maragakis collaborates with scholars based in United States, Netherlands and Japan. Nicholas J. Maragakis's co-authors include Jeffrey D. Rothstein, Angelo C. Lepore, Andrea C. Pardo, Mahendra S. Rao, Jean‐Philippe Richard, Christopher J. Donnelly, Rita Sattler, Jeremy M. Shefner, Britta Rauck and Christine M. Dejea and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Nicholas J. Maragakis

103 papers receiving 7.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

C9orf72 nucleotide repeat structures initiate molecular cascades of disease

2014 730 citations Christopher J. Donnelly, Nicholas J. Maragakis et al. profile →
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)

2002 660 citations Nicholas J. Maragakis, Jeffrey D. Rothstein et al. Proceedings of the National Academy of Sciences profile →
Mechanisms of Disease: astrocytes in neurodegenerative disease

2006 655 citations Nicholas J. Maragakis, Jeffrey D. Rothstein profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas J. Maragakis United States	44	3.3k	3.0k	2.3k	2.2k	1.4k	106	7.4k
Robert H. Baloh United States	49	3.8k 1.2×	5.0k 1.7×	3.0k 1.3×	2.1k 0.9×	1.5k 1.1×	88	9.7k
Akiyoshi Kakita Japan	56	5.4k 1.6×	4.2k 1.4×	3.0k 1.3×	1.6k 0.7×	1.9k 1.3×	439	12.3k
Ralph W. Kuncl United States	37	3.8k 1.2×	3.9k 1.3×	5.7k 2.4×	1.3k 0.6×	1.5k 1.1×	83	10.4k
Bernard L. Schneider Switzerland	54	2.9k 0.9×	3.5k 1.2×	3.2k 1.4×	461 0.2×	976 0.7×	150	8.9k
Jochen H. Weishaupt Germany	48	3.2k 1.0×	3.0k 1.0×	1.8k 0.8×	1.4k 0.6×	1.4k 1.0×	146	6.9k
Paul R. Heath United Kingdom	48	2.5k 0.8×	3.3k 1.1×	972 0.4×	1.4k 0.6×	1.3k 0.9×	131	6.7k
John Ravits United States	40	5.3k 1.6×	2.8k 0.9×	1.2k 0.5×	3.1k 1.4×	1.4k 1.0×	93	7.5k
Jasna Križ Canada	40	1.8k 0.5×	1.6k 0.5×	915 0.4×	842 0.4×	2.3k 1.6×	104	5.5k
Wim Robberecht Belgium	58	8.3k 2.5×	3.9k 1.3×	2.2k 1.0×	4.4k 2.0×	2.1k 1.5×	133	11.4k
Minh Dang Nguyen Canada	32	1.5k 0.5×	2.5k 0.8×	1.1k 0.5×	820 0.4×	1.1k 0.8×	70	5.7k

Countries citing papers authored by Nicholas J. Maragakis

Since Specialization

Citations

This map shows the geographic impact of Nicholas J. Maragakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas J. Maragakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas J. Maragakis more than expected).

Fields of papers citing papers by Nicholas J. Maragakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas J. Maragakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas J. Maragakis. The network helps show where Nicholas J. Maragakis may publish in the future.

Co-authorship network of co-authors of Nicholas J. Maragakis

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas J. Maragakis. A scholar is included among the top collaborators of Nicholas J. Maragakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas J. Maragakis. Nicholas J. Maragakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Angrick, Miguel, Shiyu Luo, Qinwan Rabbani, et al.. (2025). Real-time detection of spoken speech from unlabeled ECoG signals: a pilot study with an ALS participant. Journal of Neural Engineering. 22(5). 56023–56023. 1 indexed citations

Luo, Shiyu, Miguel Angrick, Qinwan Rabbani, et al.. (2024). A click-based electrocorticographic brain-computer interface enables long-term high-performance switch scan spelling. SHILAP Revista de lepidopterología. 4(1). 207–207. 4 indexed citations

Taga, Arens, et al.. (2024). Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model. Stem Cells Translational Medicine. 13(12). 1198–1212. 4 indexed citations

Adashek, Jacob J., Nicholas J. Maragakis, Pradip De, et al.. (2024). Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer. BMC Medicine. 22(1). 74–74. 6 indexed citations

Luo, Shiyu, Miguel Angrick, Christopher Coogan, et al.. (2023). Stable Decoding from a Speech BCI Enables Control for an Individual with ALS without Recalibration for 3 Months. Advanced Science. 10(35). e2304853–e2304853. 39 indexed citations

Kanbour, Sarah, Aanika Balaji, Nicholas J. Maragakis, Nicholas S. Clarke, & Nestoras Mathioudakis. (2023). Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndrome. SHILAP Revista de lepidopterología. 28. 100143–100143.

Taga, Arens, Jessica Joseph, Sarah K. Gross, et al.. (2022). Cx43 hemichannels contribute to astrocyte-mediated toxicity in sporadic and familial ALS. Proceedings of the National Academy of Sciences. 119(13). e2107391119–e2107391119. 42 indexed citations

Oskarsson, Björn, Nicholas J. Maragakis, Richard Bedlack, et al.. (2021). MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis in a Phase IIb/III Study: COMBAT-ALS Study Design. Neurodegenerative Disease Management. 11(6). 431–443. 29 indexed citations

Vliet, Erwin A. van, Anand M. Iyer, Jasper J. Anink, et al.. (2019). Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients. Journal of Neuropathology & Experimental Neurology. 79(3). 266–276. 23 indexed citations

10.

Konràd, Csaba, Hibiki Kawamata, Andrea J. Arreguin, et al.. (2017). Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Molecular Neurodegeneration. 12(1). 76–76. 47 indexed citations

11.

Fournier, Christina, Hiroshi Mitsumoto, Catherine Lomen‐Hoerth, et al.. (2016). Primary Lateral Sclerosis and Early Upper Motor Neuron Disease. Journal of Clinical Neuromuscular Disease. 17(3). 99–105. 17 indexed citations

12.

Haidet-Phillips, Amanda, et al.. (2014). Human glial progenitor engraftment and gene expression is independent of the ALS environment. Experimental Neurology. 264. 188–199. 17 indexed citations

13.

Maragakis, Nicholas J., et al.. (2014). Influence of botulinum toxin in injection in gait velocity of patients with lower limb spasticity. Annals of Physical and Rehabilitation Medicine. 57. e51–e51. 1 indexed citations

14.

Haidet-Phillips, Amanda, Laurent Roybon, Sarah K. Gross, et al.. (2014). Gene Profiling of Human Induced Pluripotent Stem Cell-Derived Astrocyte Progenitors Following Spinal Cord Engraftment. Stem Cells Translational Medicine. 3(5). 575–585. 32 indexed citations

15.

Chad, David A., Lewis P. Rowland, Carmel Armon, et al.. (2013). Peer recommendations on how to improve clinical research, and Conference wrap-up. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 14(sup1). 67–73. 1 indexed citations

16.

Haidet-Phillips, Amanda, Sarah K. Gross, Timothy L. Williams, et al.. (2013). Altered astrocytic expression of TDP-43 does not influence motor neuron survival. Experimental Neurology. 250. 250–259. 43 indexed citations

17.

Maragakis, Nicholas J., Neil R. Holland, & Andrea M. Corse. (2013). Hemiparetic Primary Lateral Sclerosis: Revisiting Mills Syndrome. Case Reports in Neurology. 7(3). 191–195. 8 indexed citations

18.

Lepore, Angelo C., John O’Donnell, Timothy L. Williams, et al.. (2011). Human Glial-Restricted Progenitor Transplantation into Cervical Spinal Cord of the SOD1G93A Mouse Model of ALS. PLoS ONE. 6(10). e25968–e25968. 87 indexed citations

19.

Laird, Fiona M., Mohamed H. Farah, Steven Ackerley, et al.. (2008). Motor Neuron Disease Occurring in a Mutant Dynactin Mouse Model Is Characterized by Defects in Vesicular Trafficking. Journal of Neuroscience. 28(9). 1997–2005. 143 indexed citations

20.

Maragakis, Nicholas J. & Jeffrey D. Rothstein. (2001). Glutamate Transporters in Neurologic Disease. Archives of Neurology. 58(3). 365–70. 258 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact